International Symposium on Malignant Mesothelioma 2022
Mesothelioma Applied Research Foundation Symposium 2022
On July 22 and 23 of 2022, the Mesothelioma Applied Research Foundation (MARF) will hold its annual International Symposium on Malignant Mesothelioma in Chicago, Illinois. MARF is the only nonprofit charitable organization dedicated to ending mesothelioma and its detrimental effects. Since 2004, MARF has gathered prominent mesothelioma experts alongside those affected by the condition for a symposium. The two-day event aims to bring together the entire mesothelioma community including patients, families, caregivers, and experts to find community and support.
The symposium will take place over two days – Friday, July 22, and Saturday, July 23, 2022, at Summit Chicago in Chicago, Illinois. Continue reading to find out more about this educational event and what to expect from the 2022 International Symposium on Malignant Mesothelioma.
International Symposium on Malignant Mesothelioma Speakers
The Symposium will host the nation’s top mesothelioma doctors speaking on a variety of topics similar to past events.
Mesothelioma specialists such as Hedy Kindler, Shannon Sinclair, Travis Grotz, Raffit Hassan, Muaiad Kittaneh, and many more will speak while at the conference. These speakers will stand alongside world-renowned medical centers like Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center.
International Symposium on Malignant Mesothelioma Agenda
The symposium will take place over two days and will cover a large array of topics from what to look for in a doctor and clinical trials to support groups and financial issues. The full event agenda is detailed below.
|Friday, July 22, 2022|
|4:00 – 6:00 PM||Welcome Reception*|
|Saturday, July 23, 2022|
|7:30 AM||Continental Breakfast*|
|8:00 – 8:15 AM||Opening Remarks*|
|8:15 – 10:25 AM||Loss and Bereavement Sessions and Celebration of Life Ceremony***|
|8:15 – 8:35 AM||Mesothelioma 101*|
|8:35 – 9:05 AM||Systematic Therapies for Pleural and Peritoneal Mesothelioma*|
|9:05 – 9:35 AM||Treatment Options for Peritoneal Mesothelioma*|
|9:35 – 10:05 AM||Clinical Trials’ Considerations*|
|10:05 – 10: 25 AM||Life During Treatment*|
|10:45 – 11:20 AM||Surgical and Multi-Modality Treatment Options for Pleural Mesothelioma*|
|11:20 – 11:40 AM||Fighting Mesothelioma with Genetics, the Tumor Microenvironment, and the Immune System*|
|11:40 AM – 12:00 PM||Radiation Oncology / Radiation Therapy for Mesothelioma*|
|12:00 – 12:20 PM||Awards Recipients’ Recognition*|
|1:30 – 2:30 PM||Community Sessions and Support**/***|
|3:00 – 3:45 PM||Ins and Outs of Asbestos Litigation for Patients and their Families*|
|3:45 – 4:15 PM||News from the Scientific Meeting*|
|4:15 – 4:30||Closing*|
**Patients and Family
Registering for the 2022 Symposium
If you would like to partake in the event, you can register at the Mesothelioma Applied Research Foundation’s website. The 2022 symposium will take place at Summit Chicago in Chicago, Illinois. Interested parties can attend the event in person for a small fee or via Livestream for free. Below are some of the discussions we at Mesothelioma Hub are looking forward to the most.
Shannon Sinclair, RN, BSN, OCN from the Mesothelioma Applied Research Foundation will begin the symposium by introducing the serious condition of mesothelioma and what to expect from the conference. Sinclair will give an overview of medical jargon, acronym meanings, how to understand data, and disease basics from 8:15 to 8:35 AM.
Systemic Therapies for Pleural and Peritoneal Mesothelioma
The systemic therapies session welcome to all will be hosted by Hedy Kindler, MD from the University of Chicago Medicine from 8:35 to 9:05 AM. The session will discuss systemic therapies currently available to patients including chemotherapy, immunotherapy, VEGF inhibitors, precision medicine, and targeted therapies, and will be followed by a Q&A session.
Clinical Trials’ Considerations
From 9:35 to 10:05 AM, Raffit Hassan, MD, NCI, will speak about clinical trials’ considerations. The session will cover clinical trials currently available, eligibility, considerations, administration, and locations.
Fighting Mesothelioma with Genetics, the Tumor Microenvironment, and the Immune System
From 11:20 to 11:40 AM, the fighting mesothelioma session will occur. The session will include speakers like Cara Haymaker, PhD, MD from Anderson Cancer Center, and Myuaiad Kittaneh, MD. This session will help listeners understand genetic mutations, the tumor microenvironment, and the immune system’s involvement in the development of mesothelioma and how scientists use that knowledge to develop new mesothelioma treatments.